Circuit-Selective Striatal Synaptic Dysfunction in the Sapap3 Knockout Mouse Model of Obsessive-Compulsive Disorder by Wan, Yehong et al.
Circuit-selective striatal synaptic dysfunction in the Sapap3
knockout mouse model of obsessive-compulsive disorder
Yehong Wan1, Kristen Ade1, Zachary Caffall1, M. Ilcim Ozlu3, Cagla Eroglu2,3, Guoping
Feng4, and Nicole Calakos1,2
1Department of Medicine, Division of Neurology, Duke University, Durham, North Carolina 27710,
USA
2Department of Neurobiology, Duke University, Durham, North Carolina 27710, USA
3Department of Cell Biology, Duke University, Durham, North Carolina 27710, USA
4Department of Brain and Cognitive Sciences, McGovern Institute for Brain Research, MIT,
Cambridge, MA 02139, USA
Abstract
Background—SAP90/PSD-95-associated protein 3 (SAPAP3, also DLGAP3 or GKAP3) is an
excitatory postsynaptic protein implicated in the pathogenesis of obsessive-compulsive behaviors.
In mice, genetic deletion of Sapap3 causes obsessive-compulsive disorder (OCD)-like behaviors
that are rescued by striatal expression of Sapap3, demonstrating the importance of striatal
neurotransmission for the OCD-like behaviors. In the striatum, there are two main excitatory
synaptic circuits, corticostriatal and thalamostriatal. Neurotransmission defects in either or both of
these circuits could potentially contribute to the OCD-like behaviors of Sapap3 knockout (KO)
mice. Previously we reported that Sapap3 deletion reduces corticostriatal AMPA-type glutamate
receptor (AMPAR)-mediated synaptic transmission.
Methods—Whole-cell electrophysiological recording techniques in acute brain slices were used
to measure synaptic transmission in the corticostriatal and thalamostriatal circuits of Sapap3 KO
mice and littermate controls. Transgenic fluorescent reporters identified striatopallidal and
striatonigral projection neurons. SAPAP isoforms at corticostriatal and thalamostriatal synapses
were detected using immunostaining techniques.
Results—In contrast to corticostriatal synapses, thalamostriatal synaptic activity is unaffected by
Sapap3 deletion. At the molecular level, we find that another SAPAP family member, SAPAP4, is
present at thalamostriatal, but not corticostriatal synapses. This finding provides a molecular
rationale for the functional divergence we observe between thalamic and cortical striatal circuits in
Sapap3 KO mice.
Conclusion—These findings define the circuit-level neurotransmission defects in a genetic
mouse model for OCD-related behaviors, focusing attention on the corticostriatal circuit for
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mediating the behavioral abnormalities. Our results also provide the first evidence that SAPAP
isoforms may be localized to synapses according to circuit-selective principles.
Keywords
obsessive-compulsive disorder; SAPAP3; striatum; thalamostriatal; corticostriatal; GKAP;
DLGAP3
Introduction
SAPAPs (also known as guanylate kinase-associated proteins, GKAPs or DLGAPs) are a
family of postsynaptic scaffold proteins that are unique to excitatory synapses and well
poised to influence synaptic activity of ionotropic and metabotropic glutamate receptors by
virtue of their interaction with proteins such as PSD-95 and Shank (1-6). Loss of SAPAP3,
the only SAPAP highly expressed in striatum, causes pathological grooming and anxiety-
like behaviors in mice suggesting relevance to obsessive-compulsive disorder (OCD) (7).
Sapap3 KO mice show excessive self-grooming and develop facial lesions. Anxiety-like
behaviors as detected in the elevated zero maze, open field test, and light-dark emergence
assay are also present. Predictive validity of this model is indicated by the finding that the
entire constellation – self-grooming, facial lesions and anxiety-like behaviors – is alleviated
by chronic (5 d.) treatment with a selective serotonin reuptake inhibitor, a first-line treatment
for OCD. More recent evidence from human genetic studies also supports a role for SAPAPs
in obsessive-compulsive behaviors (8-10).
Human neuroimaging studies of OCD have identified abnormalities throughout the cortico-
striato-thalamo-cortical circuitry (11). However, determining which regions may be the
origins of abnormal activity and which regions are driven abnormally as a consequence of a
proximal insult is difficult to elucidate in this experimental approach. In Sapap3 KO mice,
the circuit basis for the OCD-like behaviors has been localized to the striatum through
rescue experiments in which lentiviral-mediated expression of Sapap3 limited to the
striatum was sufficient to prevent the behavioral defects (7). Given the striatal-dependent
OCD-like behaviors of Sapap3 KO mice, a detailed understanding of the striatal circuit
changes in Sapap3 KO mice can identify potential circuit mechanisms for behaviors relevant
to OCD. In recent work, we found that Sapap3 deletion reduces corticostriatal AMPAR-
mediated synaptic transmission (6), but the integrity of thalamostriatal transmission was not
examined.
The striatum, the input nucleus of the basal ganglia, receives excitatory afferents from both
cerebral cortex and thalamus. Corticostriatal and thalamostriatal circuits differentially
contribute to behavior (12, 13). Corticostriatal and thalamostriatal synapses onto medium
spiny neurons (MSNs) are also known to have different anatomical and physiological
properties (14-17). Finally, although ultrastructural properties of postsynaptic spines have
been compared between corticostriatal and thalamostriatal synapses (18), little is known
about molecular differences in the postsynaptic density which may give rise to such
differences.
In this study, we examined the integrity of thalamostriatal synaptic transmission in
striatonigral and striatopallidal MSNs of Sapap3 KO mice. Surprisingly, our results show
that Sapap3 deletion does not affect thalamostriatal AMPAR synaptic activity. Consistent
with this circuit-selective functional difference (i.e. impaired corticostriatal and preserved
thalamostriatal activity), we find that another isoform, SAPAP4 is present at thalamostriatal
synapses, but not corticostriatal synapses. This finding reveals for the first time a
postsynaptic molecular specificity in MSNs that distinguishes two striatal inputs, while the
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associated circuit-selective functional impairment of excitatory synaptic transmission in
Sapap3 KO mice advances our circuit-level understanding of OCD-like behaviors.
Materials and Methods
Brain slice preparation
Animal procedures were performed according to protocol approved by the Institutional
Animal Care and Use Committee of Duke University. Generation of Sapap3 KO, Drd1a-
tdTomato(tg/+) transgenic, and Drd2-EGFP(tg/+) transgenic mice has been previously
described (7, 19, 20). From littermate pairs of P21–25 Sapap3 wild-type (WT) and KO mice
hemizygous for Drd1a-tdTomato and/or Drd2-EGFP transgenes, acute coronal or
parahorizontal brain slices (300 μm thickness) were obtained as previously described (6,
14). All experiments were performed with experimenter blinded to Sapap3 genotype.
Electrophysiology
Recordings were obtained at room temperature (23-25°C). GABAA receptors were blocked
by 50 μM picrotoxin (Sigma-Aldrich). Glycine (1 μM) was present in NMDA-type
glutamate receptor (NMDAR)-mediated excitatory postsynaptic current (EPSC)
experiments. According to their axonal projection patterns, striatal MSNs are classified into
two types, striatonigral (SN) and striatopallidal (SP) MSNs (21). Since the two types of
MSNs have different synaptic properties (22), transgenic mice expressing fluorescent
marker proteins were used to distinguish SN and SP MSNs (20). Whole-cell patch-clamp
recordings were made as described in (6).
Cortical afferents were evaluated using coronal slices with stimulating electrode placed in
corpus callosum adjacent to dorsolateral striatum. Thalamic afferents were evaluated using
parahorizontal slices with stimulating electrode placed in thalamus close to medial border of
the thalamic reticular nucleus (14). To evoke EPSCs, 150-μs duration stimuli were delivered
at 0.05 Hz through a bipolar electrode made of monopolar tungsten electrodes (FHC).
Paired-pulse ratios were calculated by the ratio of the peak of the second EPSC to the peak
of the first EPSC using a 50-ms inter-stimulus interval. AMPAR/NMDAR ratio was
calculated by the ratio of the peak of the EPSC at -70 mV to the magnitude of the EPSC at
+40 mV at 60 ms following stimulation.
Miniature EPSCs (mEPSCs) were recorded in 1 μM tetrodotoxin (TTX; Tocris) and
analyzed using Mini Analysis Program software (Synaptosoft). Quantal EPSCs (qEPSCs)
during the asynchronous phase of evoked release were recorded in standard ACSF
containing 0 mM Ca2+, 2 mM Sr2+ and 50 uM AP-5 (Tocris). AMPAR-mediated qEPSCs
were analyzed during a 300 ms period beginning 50 ms after each stimulus. For mEPSC and
qEPSC analysis, threshold amplitude for detection of events was 5 pA.
Primary co-cultures and immunostaining
Corticostriatal and thalamostriatal co-cultures were prepared from P0 Sapap3 WT mice as
previously described (5) with the modification that thalamic tissue was used for
thalamostriatal cultures and plated in a ratio of 1:1 of thalamic and striatal cells. On DIV
13-14, cultures were fixed and immunostained as previously described (5). Primary
antibodies were: anti-vGluT1 mouse monoclonal antibody (1:400; Synaptic Systems
135511), anti-vGluT2 guinea pig polyclonal antibody (1:200; Synaptic Systems 135404),
anti-SAPAP4 rabbit polyclonal antibody (1:400) (3), and anti-DARPP32 rat monoclonal
antibody (1:60; R&D Systems MAB4230). Affinity-purified SAPAP4 antibody was
generated against a His-tagged fusion protein encoding SAPAP4 amino acids 612-689 as
previously described (3). SAPAP4 isoform-selectivity was demonstrated previously using
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Western blot analysis to discriminate SAPAP isoforms by molecular weight (3). Primary
antibody incubations were performed at 4°C overnight. Appropriate secondary antibodies
(Alexa Fluor 488-conjugated goat anti-mouse IgG, Alexa Fluor 568-conjugated goat anti-
guinea pig IgG, Alexa Fluor 488-conjugated goat anti-guinea pig IgG, Alexa Fluor 568-
conjugated goat anti-rabbit IgG, 1:800, Molecular Probes; Cy5-conjugated donkey anti-rat
IgG, 1:200, Jackson ImmunoResearch) were incubated for 2 hours at room temperature after
washing primary antibody incubation solution and re-blocking. Images were obtained using
a 40×/1.3 oil objective on an LSM 510 confocal microscope (Zeiss). Alexa Fluor 488 dye
was excited with a 488 nm Argon laser. Alexa Fluor 568 dye was excited with a 561 nm
diode laser. Cy5 dye was excited with a 633 nm HeNe laser. No cross talk between channels
was detected under these settings. MetaMorph software (Molecular Devices) was used for
analysis. MSN dendrites were identified by DARPP32 staining (indicator of medium spiny
neurons) and selected for analysis if they did not have other dendrites overlying. The
percentage of colocalized area was defined as the percentage of vGluT1 or vGluT2-positive
area that was also labeled with SAPAP4.
Brain slice immunostaining
Immunostaining in brain slices was performed as previously described (23). Briefly, P21-25
mice were perfused with Tris-buffered saline (TBS) followed by 4% paraformaldehyde
(PFA). Brains were immersed in 4% PFA/30% sucrose solution overnight at 4°C. Tissue
was embedded in a 2:1 mixture of 20% sucrose in phosphate-buffered saline (PBS):OCT
(Tissue-Tek, Cat. No: 4583) in PBS, and cryo-sectioned (coronal, 20 μm). Brain slices were
incubated for 72 hours at 4°C with primary antibodies: guinea pig anti-vGluT2 antibody
(1:2500; Millipore, AB5905) and rabbit anti-SAPAP4 antibody (1:400) (3). Secondary
Alexa-488-conjugated goat anti-guinea pig IgG (1:500; Invitrogen) and Alexa 594-
conjugated goat anti-rabbit IgG (1:500; Invitrogen) antibodies were used for detection of
primary antibodies. Slides were mounted in Vectashield (Vector Laboratories Inc.) with
DAPI (i.e. 4’,6-diamidino-2-phenylindole) and imaged on a Leica SP5 confocal laser-
scanning microscope using a 63× oil objective. For each tissue slice, serial optical sections
at 0.33 μm intervals were acquired over a total depth of 5 μm for a total of 15 optical
sections. Maximum intensity projections (MIPs) were generated from 3 consecutive sections
yielding MIPs representing 1μm of depth each. To analyze co-localization of vGluT2- and
SAPAP4-postive puncta, MIPs were quantified using the Puncta Analyzer program in
ImageJ 1.26 (23). The percentage of colocalized area was defined as the percentage of
SAPAP4 area that was also labeled with vGluT2.
Statistical analysis
All data presented as mean ± standard error of the mean. Error bars indicate standard error
of the mean. Group results were compared by t-test, ANOVA, or Mann-Whitney test.
Asterisk indicates a p-value of < 0.05.
Results
In striatopallidal MSNs, circuit-selective analysis is necessary to reveal defect in quantal
synaptic events
Circuit-selective studies to examine thalamostriatal transmission were prompted by finding
that SP MSNs had discordant effects of Sapap3 deletion on miniature and evoked EPSCs. In
prior studies, we demonstrated that Sapap3 deletion reduced AMPAR-mediated evoked
EPSCs in both SN and SP MSNs (6). In SN MSNs, this was accompanied by a significant
reduction in the frequency of mEPSC events (6). However, in SP MSNs, we show here that
mEPSCs are unaffected by Sapap3 deletion. No significant differences were detected in
either frequency or amplitude (frequency: WT, 4.1 ± 0.4 Hz, 22 cells; KO, 3.7 ± 0.3 Hz, 22
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cells; p = 0.416, t-test; Figure 1A, B; amplitude: WT, -14.3 ± 0.3 pA, 22 cells; KO, -15.2 ±
0.4 pA, 22 cells; p = 0.152, Mann-Whitney; Figure 1A, C).
To investigate the reason for this incongruence, we considered whether differences in the
source of afferent fibers contributing to each type of synaptic response (i.e. miniature vs.
evoked) could explain our observations. Evoked EPSCs (eEPSCs) are biased towards inputs
activated by the experimenter’s stimulating electrode, whereas mEPSC events reflect all
inputs and are not dependent upon electrode stimulation. To specifically evaluate quantal
events that come from the population of synapses activated in the evoked EPSC
experiments, we analyzed quantal EPSCs elicited by evoking EPSCs in the presence of Sr2+
(in place of Ca2+) (14, 24). In the presence of Sr2+, action potential-dependent presynaptic
neurotransmitter release events are significantly prolonged resulting in asynchronous quantal
events after the initial synchronous release. Using this approach, we first validated that
qEPSC event analysis could detect an impairment in event frequency as we previously
observed for mEPSCs in Sapap3 KO SN neurons (6). Upon cortical stimulation, we found
that qEPSC frequency was reduced in Sapap3 KO SN MSNs (WT, 45.5 ± 3.8 Hz, 13 cells;
KO, 34.9 ± 3.0Hz, 13 cells; p = 0.038, t-test; Figure 2A-D). These results are consistent with
our published findings of both a reduced mEPSC frequency and reduced corticostriatal
evoked EPSC amplitudes in Sapap3 KO SN MSNs (6).
We then asked whether qEPSC frequency deriving from cortical afferents was reduced in SP
MSNs of Sapap3 KO mice. In SP MSNs, the frequency of qEPSCs elicited by cortical
stimulation was reduced in Sapap3 KO mice (frequency: WT, 33.6 ± 3.9 Hz, 13 cells; KO,
20.9 ± 3.4 Hz, 13 cells; p = 0.022, t-test; amplitude: WT, -19.4 ± 0.6 pA, 13 cells; KO, -17.6
± 0.9 pA, 13 cells; p = 0.061, Mann-Whitney; Figure 2E-G). These results reveal that
corticostriatal synaptic quantal events are impaired in SP MSNs. These results are consistent
with our published finding of reduced SP MSN corticostriatal eEPSCs in Sapap3 KO mice
(6) and are in contrast to our mEPSC analysis, a measure that is not circuit-selective (Figure
1A-C).
AMPAR activity at thalamostriatal synapses is unaffected by Sapap3 deletion
The discordant results between mEPSCs and eEPSCs of SP MSNs raise the possibility that a
subpopulation of excitatory synapses onto MSNs might be unaffected by Sapap3 deletion. If
present, the contribution of such a synaptic population to mEPSCs could obscure detection
of the impairment among corticostriatal synapses. The striatum has two major sources of
excitatory afferents: cortex and thalamus. To test whether Sapap3 deletion affected
thalamostriatal synapses, we employed a parahorizontal slice preparation that allows
selective activation of these inputs (Figure 3A) (14, 16). Consistent with our goal of
stimulating a distinct subset of MSN inputs, paired-pulse ratios (PPRs) of evoked EPSCs
resulting from thalamic and cortical stimulation differed (SP MSNs: cortical, 1.06 ± 0.03, 23
cells; thalamic, 0.66 ± 0.05, 15 cells; p < 0.001, Mann-Whitney; Figure 3B; SN MSNs:
cortical, 0.98 ± 0.03, 29 cells; thalamic, 0.73 ± 0.06, 19 cells; p < 0.001, Mann-Whitney;
Figure 3C) and were similar to values previously reported in mouse for corticostriatal and
thalamostriatal synapses in these two MSN populations (14).
Using the approach we employed at corticostriatal synapses, we analyzed qEPSCs at
thalamostriatal synapses in SP and SN MSNs from Sapap3 KO and WT mice. In both SP
and SN MSNs, we found no significant difference between WT and Sapap3 KO mice in
thalamic qEPSC frequency or amplitude (frequency – SP MSNs: WT, 14.4 ± 1.5 Hz, 11
cells; KO, 12.7 ± 1.2 Hz, 12 cells; p = 0.378, t-test; Figure 3D, E; SN MSNs: WT, 19.1 ± 2.2
Hz, 13 cells; KO, 20.0 ± 2.1 Hz, 15 cells; p = 0.765, t-test; Figure 3G, H; amplitude – SP
MSNs: WT, -17.8 ± 0.8 pA, 11 cells; KO, -19.2 ± 0.7 pA, 12 cells; p = 0.268, Mann-
Whitney; Figure 3D, F; SN MSNs: WT, -21.1 ± 0.9 pA, 13 cells; KO, -21.2 ± 0.8 pA, 15
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cells; p = 0.782, Mann-Whitney; Figure 3G, I). Likewise, AMPAR/NMDAR ratios of
thalamic eEPSCs in SP and SN MSNs of Sapap3 KO mice were normal (SP MSNs: WT,
3.22 ± 0.35, 16 cells; KO, 3.38 ± 0.30, 16 cells; p = 0.429, Mann-Whitney; Figure 3J; SN
MSNs: WT, 2.76 ± 0.20, 19 cells; KO, 3.24 ± 0.31, 16 cells; p = 0.246, Mann-Whitney;
Figure 3L). Finally, thalamostriatal PPRs were normal in both SP and SN MSNs of Sapap3
KO mice (SP MSNs: WT, 0.66 ± 0.05, 15 cells; KO, 0.57 ± 0.05, 16 cells; p = 0.236, Mann-
Whitney; Figure 3K; SN MSNs: WT, 0.73 ± 0.06, 19 cells; KO, 0.73 ± 0.06, 16 cells; p =
0.741, Mann-Whitney; Figure 3M). These results indicate that Sapap3 deletion has a circuit-
selective effect on excitatory synaptic transmission in both SP and SN MSNs – decreasing
corticostriatal, but not thalamostriatal responses.
Molecular heterogeneity of SAPAPs at corticostriatal and thalamostriatal synapses
The most straightforward explanation for the differential alteration of striatal synapses by
Sapap3 deletion in thalamic and cortical circuits is that another SAPAP may be localized at
thalamostriatal synapses. While SAPAP3 is the sole SAPAP that is highly expressed in the
striatum, low levels of expression of other SAPAPs are detectable in striatum (3). Using
quantitative real-time PCR, we measured mRNA abundance for each of the SAPAP family
members in striatal tissue and found that SAPAP4 mRNA was the next most abundant
(Figure S2 in Supplement 1). To determine whether SAPAP4 is present at thalamostriatal
synapses of MSNs, we examined SAPAP4 immunostaining in striatal slices using vGluT2 as
a marker for thalamic synaptic puncta. vGluT2 colocalizes with thalamostriatal terminals
from certain intralaminar nuclei and does not colocalize with corticostriatal terminals
(25-29). Punctate SAPAP4 immunostaining was readily detectable in striatum colocalizing
with vGluT2 (WT: 30.0 ± 0.6 %, 20 regions; KO: 36.8 ± 1.2 %, 20 regions; Figure 4A, B).
To determine whether SAPAP4 was circuit-selectively targeted to thalamostriatal but not
corticostriatal synapses, we took advantage of co-cultured neuronal preparations to isolate
and define the afferent source and to reduce the density of staining thereby increasing the
specificity of colocalizing signal. Corticostriatal synapses are associated with vGluT1 and
not vGluT2 whereas vGluT2 is a specific marker for some, but not all, thalamostriatal
synapses (27-29). By co-culturing striatal tissue with either cortex or thalamus, we
reproduced the expected divergent expression pattern of vGluTs in primary neuronal
cultures (Figure 5A). Using the co-culture preparation, we found that, as predicted from
tissue studies, vGluT2-positive puncta were present only on MSNs in thalamostriatal co-
cultures. Corticostriatal co-cultures contained vGluT1- but not vGluT2-positive puncta. Note
that vGluT1 signaling was detected in both types of co-cultures, consistent with prior results
showing vGluT1 mRNA in some thalamic regions that project to striatum (27-29).
Therefore, we used vGluT2 as a specific marker of thalamic terminals in thalamostriatal co-
cultures and vGluT1 as a marker for cortical terminals in corticostriatal co-cultures. Using
the corresponding vGluT marker for each culture type, we evaluated the co-localization of
SAPAP4 and vGluT on MSN dendrites (identified by DARPP32 immunostaining). In
thalamostriatal co-cultures, SAPAP4 was readily detected at vGluT2-positive puncta, while
in corticostriatal co-cultures, there was no discernable SAPAP4 signal at vGluT1-positive
puncta (thalamostriatal: vGluT2 and SAPAP4 colocalization/total vGluT2×100; 40.5 ± 2.4
%, 43 DARPP32+ dendritic regions; corticostriatal: vGluT1 and SAPAP4 colocalization/
total vGluT1×100; 0.7 ± 0.1 %, 57 DARPP32+ dendritic regions; p < 0.001, Mann-Whitney;
Figure 5B, C). These findings indicate that MSNs assemble postsynaptic structures in a
circuit-specific manner, with SAPAP4 present at thalamostriatal synapses, but not
corticostriatal synapses.
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Discussion
In the present study, we show for the first time that the activity of excitatory synapses onto
striatal MSNs is circuit-selectively altered in the Sapap3 KO mouse model of obsessive-
compulsive disorder. In explaining the basis for this functional divergence, we identify a
novel difference in the postsynaptic molecular composition of corticostriatal and
thalamostriatal synapses – SAPAP4 being present at thalamostriatal, but not corticostriatal,
synapses. These observations advance both our understanding of the circuit basis for
neuropsychiatric behaviors as modeled in mice and of properties that distinguish
corticostriatal from thalamostriatal synapses. Because the OCD-like behaviors of Sapap3
KO mice are known to derive from striatal excitatory synaptic dysfunction (7), our finding
that thalamostriatal synapses are unaffected focuses attention on the corticostriatal circuit
defects for its role in the OCD-like behaviors.
Functional and anatomical differences have been described between corticostriatal and
thalamostriatal synapses (14-17). In this study, we identify a novel difference in molecular
composition of the postsynaptic scaffold between cortical and thalamic synapses onto
MSNs. Thalamostriatal synapses, but not corticostriatal synapses, contain SAPAP4. At
present we cannot say whether the corollary is true, i.e. that SAPAP3 is present at
corticostriatal but not thalamostriatal synapses, or whether the 3 isoform is targeted to both
synapse types, since suitable SAPAP3 antibody reagents are not available. While it is known
that there is great molecular diversity at synapses and that most synaptic proteins have
multiple isoforms, there are relatively few examples of the principles guiding the
distribution of the various isoforms. The few known examples generally concern
neurotransmitter receptor subtypes that can be readily discriminated using
electrophysiological and pharmacological techniques (30, 31). Our results reveal that MSNs
have differential composition of SAPAP scaffold proteins at their postsynaptic densities
according to neural circuitry. These results provide one of the first examples of principles
guiding postsynaptic scaffold molecular diversity.
In the present study, both SP and SN MSNs of Sapap3 KO mice had defects in
corticostriatal but not thalamostriatal synaptic activity. It is interesting to consider why a
reduction in mEPSC frequency was readily detectable in SN but not SP MSNs. One
possibility for why a defect in mEPSC frequency was more easily detected in SN MSNs
could be that corticostriatal synapses of Sapap3 KO mice are more impaired in SN MSNs
than SP MSNs. However, our corticostriatal eEPSC data suggest just the opposite (see
Figure 1 in ref. 6). Another possibility is that thalamic inputs contribute to a greater
proportion of synaptic activity in SP than SN MSNs. In mice, SP and SN MSNs have been
reported to have similar proportions of structural synaptic contacts from cortex and thalamus
(32). On the other hand, our results do indicate that a functional bias towards thalamostriatal
synapses may exist in SP MSNs relative to SN MSNs. Our PPR data suggest a mechanism
for this bias. Assuming that the observed PPR differences reflect relative differences in
release probability, it is noteworthy, first, that in both SP and SN MSNs, PPR is lower for
thalamostriatal synapses than corticostriatal synapses. This predicts that release probability
may be higher in thalamostriatal synapses and would increase their relative contribution.
Second, the difference in PPR between cortical and thalamic synapses is greater for SP than
SN MSNs (T-S and C-S, F = 141.72, p < 0.001; T-S and C-S × SP and SN, F = 7.10, p =
0.008; three-way ANOVA; T-S, 66 cells; C-S, 100 cells; SP, 76 cells; SN, 90 cells; WT, 86
cells; KO, 80 cells), indicating that the effect of this functional bias favoring thalamostriatal
synapses should be greater in SP than SN MSNs, consistent with our observations.
One of the promises of the application of molecular genetics to the study of behavior in
animal models is the ability to precisely map behaviors onto neural circuits. Sapap3 KO
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mice have been useful in this effort, as the OCD-like constellation of behaviors can be
rescued by Sapap3 expression confined to the striatum (7). These experiments thus map the
behaviors to striatum. OCD-like behaviors in Sapap3 KO mice are further localized to
excitatory synapses because SAPAPs are unique to excitatory synapses (3). However,
among excitatory synapses in the striatum, there are two major sources – afferents from the
cortex and thalamus. Striatal projection neurons receive inputs from both of these brain
regions. Thus, either or both of these circuits might be responsible for driving OCD-like
behaviors in Sapap3 KO mice. Disentangling the relative contribution of corticostriatal and
thalamostriatal circuits is difficult if not impossible using genetic techniques to manipulate
SAPAP3 expression because inputs from both brain regions target the same postsynaptic
MSN. Nevertheless, in this study, SAPAP biology serendipitously facilitated our
understanding of the circuit dysfunction underlying OCD-like behaviors. In Sapap3 KO
mice, corticostriatal AMPAR synaptic transmission is impaired, while identical measures at
thalamostriatal synapses are unaffected. These results are particularly relevant given recent
advances in using circuit-based therapies for psychiatric disease. Deep brain stimulation for
OCD is an active area of investigation and targeted regions include caudate (33). Our
finding that only a subpopulation of striatal afferents is impaired in Sapap3 KO mice
indicate that targeting select striatal input fiber tracts may increase efficacy and decrease
unnecessary modulation of unimpaired circuits. Moreover, because there are several mouse
models with OCD-like behaviors (34), some of which also have defects in corticostriatal
circuits (35-37), we now have an opportunity to determine the extent to which mouse
models with similar behaviors share common circuit defects.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Miniature EPSC events are unchanged in Sapap3 KO striatopallidal MSNs. (A)
Representative traces of mEPSC recordings from SP MSNs. Scale bars: 20 pA and 100 ms.
(B, C) Neither frequency nor amplitude of mEPSCs is significantly changed in Sapap3 KO
SP MSNs.
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Figure 2.
Circuit-selective analysis is necessary to reveal quantal event defects in corticostriatal
synaptic transmission of Sapap3 KO SP MSNs. (A) Experimental recording paradigm for
corticostriatal synapses. Ctx: cortex; c.c.: corpus callosum; Str: striatum; R: recording
electrode; S; stimulating electrode. (B) Representative traces of corticostriatal qEPSC
recordings in SN MSNs. Scale bars: 30 pA and 20 ms. (C) Frequency of corticostriatal
qEPSCs is decreased in Sapap3 KO SN MSNs. (D) No significant change in corticostriatal
qEPSC amplitude of Sapap3 KO SN MSNs is observed (WT, -21.9 ± 0.9 pA, 13 cells; KO,
-19.1 ± 0.8 pA, 13 cells; p = 0.054, Mann-Whitney). (E) Representative traces of
corticostriatal qEPSC recordings in SP MSNs. Scale bars: 30 pA and 20 ms. (F) Frequency
of corticostriatal qEPSCs is decreased in Sapap3 KO SP MSNs. (G) Amplitude of
corticostriatal qEPSCs is normal in Sapap3 KO SP MSNs.
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Figure 3.
SP and SN MSNs of Sapap3 KO mice show no alterations in thalamostriatal synaptic
transmission. (A) Experimental recording paradigm for thalamostriatal synapses. Ctx:
cortex; c.c.: corpus callosum; Str: striatum; LGP: lateral globus pallidus; i.c.: internal
capsule; Tha: thalamus; R: recording electrode; S; stimulating electrode. (B, C) Paired-pulse
ratios (PPRs) are significantly different between corticostriatal and thalamostriatal synapses
of both SP and SN MSNs. Representative traces are shown. Scale bars: 100 pA and 20 ms.
(D-I) Frequency and amplitude of thalamostriatal qEPSCs are unchanged in Sapap3 KO SP
(D-F) and SN (G-I) MSNs. Representative traces are shown. Scale bars: 30 pA and 20 ms.
(J, L) Thalamostriatal AMPAR/NMDAR ratio is normal in Sapap3 KO SP (J) and SN (L)
MSNs. Representative traces are shown. Scale bars: 100 pA and 20 ms. (K, M)
Thalamostriatal PPRs are normal in Sapap3 KO SP (K) and SN (M) MSNs.
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Figure 4.
Co-localization of SAPAP4 and vGluT2 in striatal brain slices. (A) SAPAP4 and vGluT2
immuno-fluorescence in the striatum of Sapap3 WT and KO mice. Scale bar: 10 μm. (B)
Percentage of SAPAP4 that colocalizes with vGluT2.
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Figure 5.
SAPAP4 is present at thalamostriatal, but not corticostriatal, synapses. (A) vGluT1 and
vGluT2 immuno-fluorescence on MSN dendrites in corticostriatal and thalamostriatal co-
cultures. Scale bar: 4 μm. (B) vGluT1 or vGluT2 and SAPAP4 immuno-fluorescence on
MSN dendrites in corticostriatal and thalamostriatal co-cultures. Scale bar: 4 μm. (C)
Percentage of vGluT2 that colocalizes with SAPAP4 in thalamostriatal co-cultures is
significantly higher than the percentage of vGluT1 that colocalizes with SAPAP4 in
corticostriatal co-cultures.
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